Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients-Reference-Cited by-同舟云学术

Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients

Published:2005-12-29 Issue:4 Volume:21 Page:991-998
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Locatelli Francesco,Andrulli Simeone,Memoli Bruno,Maffei Camilla,Del Vecchio Lucia,Aterini Stefano,De Simone Walter,Mandalari Antonella,Brunori Giuliano,Amato Marcello,Cianciaruso Bruno,Zoccali Carmine

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/21/4/991/12881533/gfk011.pdf

Reference16 articles.

1. Locatelli F, Aljama P, Barany P et al. European best practice guidelines working group: revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant2004; 19 [Suppl 2]: ii1–ii47

2. National Kidney Foundation I, Kidney–Dialysis Outcomes Quality Initiative: K/DOQI Clinical practice guidelines: anemia of chronic kidney disease. Am J Kidney Dis2001; 37 [Suppl]: 182–238

3. Schooley JC, Kullgren B, Allison AC. Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias. Br J Haematol1987; 67: 11–17

4. Goicoechea M, Martin J, de Sequera P et al. Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int1998; 54: 1337–1343

5. Allen DA, Breen C, Yaqoob MM, Macdougall IC. Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-gamma and TNF-alpha. J Investig Med1999; 47: 204–211

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoiesis‐stimulating agent hyporesponsiveness was associated with worse survival of hemodialysis patients independent of the serum ferritin level;Therapeutic Apheresis and Dialysis;2024-07-04

2. Impact of C-reactive protein on the effect of Roxadustat for the treatment of anemia in chronic kidney disease: a systematic review of randomized controlled trials;BMC Nephrology;2024-02-05

3. Prevalence and risk factors of erythropoiesis stimulating agents hyporesponsiveness in chronic hemodialysis patients attending nephrology center of Benghazi;Libyan Journal of Medical Research;2024-01-01

4. The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis;Medicina;2023-06-02

5. Phase angle and extracellular water-to-total body water ratio estimated by bioelectrical impedance analysis are associated with levels of hemoglobin and hematocrit in patients with diabetes;Heliyon;2023-04